Form 8-K - Current report:
SEC Accession No. 0001641172-25-008750
Filing Date
2025-05-06
Accepted
2025-05-06 07:30:33
Documents
18
Period of Report
2025-05-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42699
2 EX-4.1 ex4-1.htm EX-4.1 87020
3 EX-4.2 ex4-2.htm EX-4.2 79798
4 EX-10.1 ex10-1.htm EX-10.1 439929
5 EX-99.1 ex99-1.htm EX-99.1 13029
6 EX-99.2 ex99-2.htm EX-99.2 13495
  Complete submission text file 0001641172-25-008750.txt   999899

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE maia-20250505.xsd EX-101.SCH 3024
8 XBRL LABEL FILE maia-20250505_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE maia-20250505_pre.xml EX-101.PRE 24171
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3782
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 25915251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)